Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Equity

v3.19.1
Condensed Consolidated Statement of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional paid-in capital
Accumulated deficit
Total
Beginning balance at Dec. 31, 2017 $ 6 $ 36,202 $ (31,844) $ 4,364
Beginning balance, shares at Dec. 31, 2017 6,340,604      
Net proceeds from sale of common stock $ 1 289 290
Net proceeds from sale of common stock, shares 140,295      
Stock-based compensation expense 123 123
Stock-based compensation expense, shares 55,147      
Net loss (1,213) (1,213)
Ending balance at Mar. 31, 2018 $ 7 36,614 (33,057) 3,564
Ending balance, shares at Mar. 31, 2018 6,536,046      
Beginning balance at Dec. 31, 2018 $ 8 37,880 (35,067) 2,821
Beginning balance, shares at Dec. 31, 2018 7,481,723      
Net proceeds from sale of common stock 212 212
Net proceeds from sale of common stock, shares 111,129      
Net proceeds from private placement of stock $ 1 1,849 1,850
Net proceeds from private placement of stock, shares 1,267,123      
Issuance of common stock upon conversion of related party promissory note payable 250 250
Issuance of common stock upon conversion of related party promissory note payable, shares 171,233      
Stock-based compensation expense   42 42
Issuance of restricted stock 201 201
Issuance of restricted stock, shares 139,450      
Net loss (975) (975)
Ending balance at Mar. 31, 2019 $ 9 $ 40,434 $ (36,042) $ 4,401
Ending balance, shares at Mar. 31, 2019 9,170,658